Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B (pages 139–149)Akihiro Matsumoto, Eiji Tanaka, Yoshiyuki Suzuki, Mariko Kobayashi, Yasuhito Tanaka, Noboru Shinkai, Shuhei Hige, Hiroshi Yatsuhashi, Shinya Nagaoka, Kazuaki Chayama, Masataka Tsuge, Osamu Yokosuka, Fumio Imazeki, Shuhei Nishiguchi, Masaki Saito, Kei Fujiwara, Nobuyuki Torii, Naoki Hiramatsu, Yoshiyasu Karino and Hiromitsu Kumada
Article first published online: 22 NOV 2011 | DOI: 10.1111/j.1872-034X.2011.00910.x